Biotech · Private company · Hayward, CA, US

Pulse Biosciences, Inc.

Track this companyFree. Adds Pulse Biosciences, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials113 recruiting or active

Pipeline programs12From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

Pipeline12

CellFX DeviceWartsClinicalTrials.gov · fetched Nov 12, 2026
CellFX SystemBCC - Basal Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
CellFX SystemSkin LesionClinicalTrials.gov · fetched Nov 12, 2026
CellFX System DeviceWartsClinicalTrials.gov · fetched Nov 12, 2026
CellFX® nsPFA™ Cardiac Surgery SystemAtrial FibrillationClinicalTrials.gov · fetched Nov 12, 2026
Cryosurgery Liquid Nitrogen SprayerWartsClinicalTrials.gov · fetched Nov 12, 2026
Intralesional ElectrodesiccationSkin LesionClinicalTrials.gov · fetched Nov 12, 2026
Nano-Pulse Stimulation (NPS)Lesion SkinClinicalTrials.gov · fetched Nov 12, 2026
Nano-Pulse Stimulation (NPS)Sebaceous HyperplasiaClinicalTrials.gov · fetched Nov 12, 2026
Nano-Pulse Stimulation DeviceSkin LesionClinicalTrials.gov · fetched Nov 12, 2026
nPulse Vybrance Percutaneous Electrode SystemThyroid NoduleClinicalTrials.gov · fetched Nov 12, 2026
Ultrasound-Guided Parathyroid Nanosecond Pulsed Field Ablation (nsPFA)Primary HyperparathyroidismClinicalTrials.gov · fetched Nov 12, 2026

Clinical trials11

Treating PHPT With the nPulse™ Vybrance™ PE SystemNA · NOT_YET_RECRUITING · started Nov 30, 2026ClinicalTrials.gov NCT07912892 · fetched Nov 12, 2026
CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial FibrillationNA · RECRUITING · started Oct 23, 2025ClinicalTrials.gov NCT06959121 · fetched Nov 12, 2026
Prospective Evaluation of the Pulse Biosciences nPulse™ Vybrance™ Percutaneous Electrode SystemNA · ACTIVE_NOT_RECRUITING · started Aug 21, 2025ClinicalTrials.gov NCT07287176 · fetched Nov 12, 2026
CellFX Treat & Resect Low-Risk BCC Feasibility StudyNA · COMPLETED · started Jun 2, 2021ClinicalTrials.gov NCT04918381 · fetched Nov 12, 2026
CellFX Comparison to Cryosurgery in Cutaneous Non-Genital Common WartsNA · COMPLETED · started Feb 16, 2021ClinicalTrials.gov NCT04738734 · fetched Nov 12, 2026
Comparative Study Between CellFX and Electrodessication in Sebaceous Hyperplasia (SH) LesionsNA · COMPLETED · started Sep 28, 2020ClinicalTrials.gov NCT04539886 · fetched Nov 12, 2026
CellFX System for the Treatment of Cutaneous Non-Genital WartsNA · COMPLETED · started Jul 17, 2019ClinicalTrials.gov NCT04554394 · fetched Nov 12, 2026
Nano-Pulse Stimulation (NPS) in Seborrheic Keratosis Optimization StudyNA · TERMINATED · started Feb 5, 2019ClinicalTrials.gov NCT04249115 · fetched Nov 12, 2026
Nano-Pulse Stimulation (NPS) in Sebaceous Hyperplasia Optimization StudyNA · TERMINATED · started Dec 20, 2018ClinicalTrials.gov NCT04253418 · fetched Nov 12, 2026
Nano-Pulse Stimulation (NPS) in Sebaceous HyperplasiaNA · COMPLETED · started Jun 28, 2018ClinicalTrials.gov NCT03612570 · fetched Nov 12, 2026
Nano-Pulse Stimulation (NPS) in Seborrheic Keratosis StudyNA · COMPLETED · started May 4, 2017ClinicalTrials.gov NCT03846531 · fetched Nov 12, 2026

NIH awards1

Minimally invasive pancreatic cancer treatment combining nanosecond electric pulses and immune system stimulantsFiscal year 2025 · $303.5KNIH RePORTER 1R43CA301971-01 · fetched Nov 12, 2026